SDZXF:OTCMKTS
Sandoz Group AG
$84.03
0.00%
(0.00) 1D
Set 23, 3:20:07 PM GMT-4 · USD
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa SDZXF...
Mkt. cap
30.71B
Avg. na dami
103.00
Dami
36.00
Mataas nang 52-wk
$94.55
Mababa nang 52-wk
$60.44
Mga natitirang share
440.00M
Bilang ng mga empleyado
20K
Mkt. cap
30.71B
Avg. na dami
103.00
Dami
36.00
Mataas nang 52-wk
$94.55
Mababa nang 52-wk
$60.44
Mga natitirang share
440.00M
Bilang ng mga empleyado
20K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
AD HOC NEWS
·
6 oras ang nakalipas
Sandoz stock after-hours at EUR 74.37
AD HOC NEWS
·
8 oras ang nakalipas
Sandoz stock trades at EUR 74.52 with CHF 30.2 billion value
AD HOC NEWS
·
13 oras ang nakalipas
Sandoz loses antitrust appeal and Sandoz stock costs EUR 74.47
AD HOC NEWS
·
3 buwan ang nakalipas
EUR 75.98 at Lang & Schwarz: Sandoz stock after-hours plus 2.80 percent versus the prior close
Profile
Sandoz Group AG is a Swiss company that focuses on generic pharmaceuticals and biosimilars. Prior to October 2023, it was part of a division of Novartis that was established in 2003, when Novartis united all of its generics businesses under the name Sandoz. Before this, the company existed as an independent pharmaceutical manufacturer until 1996, when it was merged with Ciba-Geigy to form Novartis. Prior to the merger, it specialized in medicines used in organ transplants, such as Sandimmune, and various antipsychotics and migraine medicines. Its headquarters were in Holzkirchen, Germany and after the spin-off from Novartis, the headquarters moved to Basel, Switzerland, with most of global functions operating from Holzkirchen in Germany, Prague in Czechia, and Barcelona in Spain. Sandoz is the global leader in generic pharmaceuticals and biosimilars. Wikipedia
Tungkol sa Sandoz Group AG